← FDA Drug Approvals (Drugs@FDA)
ALENDRONATE SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: IPCA LABS LTD · Approved 2024-06-04
Drug application
- FDA Application #
ANDA206387- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ALENDRONATE SODIUM
- Generic name
- Alendronate Sodium
- Active ingredients
- ALENDRONATE SODIUM
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- IPCA LABS LTD
- First approval
- 2024-06-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown